HNGE PE Ratio & Valuation, Is HNGE Overvalued

Historical Valuation

Hinge Health Inc (HNGE) is now in the Fair zone, suggesting that its current forward PE ratio of 29.74 is considered Fairly compared with the five-year average of 43.64. The fair price of Hinge Health Inc (HNGE) is between 30.26 to 91.77 according to relative valuation method.

Relative Value

Fair Zone

30.26-91.77

Current Price：45.71

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Hinge Health Inc (HNGE) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Hinge Health Inc (HNGE) has a current Price-to-Book (P/B) ratio of 17.24. Compared to its 3-year average P/B ratio of 16.93, the current P/B ratio is approximately 1.85% higher. Relative to its 5-year average P/B ratio of 16.93, the current P/B ratio is about 1.85% higher. Hinge Health Inc (HNGE) has a Forward Free Cash Flow (FCF) yield of approximately 4.05%. Compared to its 3-year average FCF yield of 3.01%, the current FCF yield is approximately 34.57% lower. Relative to its 5-year average FCF yield of 3.01%, the current FCF yield is about 34.57% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for HNGE competitors is 4.83, providing a benchmark for relative valuation. Hinge Health Inc Corp (HNGE.N) exhibits a P/S ratio of 5.38, which is 11.53% above the industry average. Given its robust revenue growth of 45.60%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of HNGE increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of HNGE in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is HNGE currently overvalued or undervalued?

What is Hinge Health Inc (HNGE) fair value?

HNGE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Hinge Health Inc (HNGE) is between 30.26 to 91.77 according to relative valuation method.

How does HNGE's valuation metrics compare to the industry average?

The average P/S ratio for HNGE's competitors is 4.83, providing a benchmark for relative valuation. Hinge Health Inc Corp (HNGE) exhibits a P/S ratio of 5.38, which is 11.53% above the industry average. Given its robust revenue growth of 45.60%, this premium appears sustainable.

What is the current P/B ratio for Hinge Health Inc (HNGE) as of Mar 05 2026?

As of Mar 05 2026, Hinge Health Inc (HNGE) has a P/B ratio of 17.24. This indicates that the market values HNGE at 17.24 times its book value.

What is the current FCF Yield for Hinge Health Inc (HNGE) as of Mar 05 2026?

As of Mar 05 2026, Hinge Health Inc (HNGE) has a FCF Yield of 4.05%. This means that for every dollar of Hinge Health Inc's market capitalization, the company generates 4.05 cents in free cash flow.

What is the current Forward P/E ratio for Hinge Health Inc (HNGE) as of Mar 05 2026?

As of Mar 05 2026, Hinge Health Inc (HNGE) has a Forward P/E ratio of 29.74. This means the market is willing to pay $29.74 for every dollar of Hinge Health Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Hinge Health Inc (HNGE) as of Mar 05 2026?

As of Mar 05 2026, Hinge Health Inc (HNGE) has a Forward P/S ratio of 5.38. This means the market is valuing HNGE at $5.38 for every dollar of expected revenue over the next 12 months.

HNGE Valuation